About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Kdm6atm1.1Afst
targeted mutation 1.1, A Stewart
MGI:5499290
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Kdm6atm1.1Afst/Kdm6atm1.1Afst
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6NTac MGI:5499565
cn2
Kdm6atm1.1Afst/Y
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6NTac MGI:5499566


Genotype
MGI:5499565
cn1
Allelic
Composition
Kdm6atm1.1Afst/Kdm6atm1.1Afst
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6NTac
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm9(cre/ESR1)Arte mutation (2 available); any Gt(ROSA)26Sor mutation (993 available)
Kdm6atm1.1Afst mutation (0 available); any Kdm6a mutation (40 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system
• in tamoxifen-treated mice
• in tamoxifen-treated mice
• in the spleen of tamoxifen-treated mice
• in tamoxifen-treated mice
• anemic appearance of the bones in tamoxifen-treated mice
• tamoxifen-treated mice exhibit disturbed cell distribution with pronounced dysplasia and disrupted maturation in the erythroid, megakaryocytic and granulocytic lineages compared with control mice
• bone marrow from tamoxifen-treated mice exhibit reduced formation of colony forming units compared with control mice
• however, tamoxifen-treated mice exhibit normal numbers of hematopoietic stem cells
• decreased granulocyte-macrophage progenitors and macrophage colony numbers from bone marrow of tamoxifen-treated mice
• abnormal nuclear lobation and atypical mitosis in tamoxifen-treated mice
• in tamoxifen-treated mice
• in tamoxifen-treated mice
• in tamoxifen-treated mice
• in tamoxifen-treated mice
• dysplastic granulocytes with nuclear hyposegmentation in tamoxifen-treated mice
• in tamoxifen-treated mice
• in the spleen of tamoxifen-treated mice
• relative in tamoxifen-treated mice
• impaired migration in hematopoietic stem and progenitor cells of tamoxifen-treated mice

cellular
• increased chromosomal double-strand breaks and numerical and structural chromosomal aberrations 2 weeks after tamoxifen-treatment

growth/size/body
• in tamoxifen-treated mice
• in tamoxifen-treated mice
• in tamoxifen-treated mice

skeleton
• anemic appearance of the bones in tamoxifen-treated mice

immune system
• in tamoxifen-treated mice
• in tamoxifen-treated mice
• dysplastic granulocytes with nuclear hyposegmentation in tamoxifen-treated mice
• in the spleen of tamoxifen-treated mice
• relative in tamoxifen-treated mice




Genotype
MGI:5499566
cn2
Allelic
Composition
Kdm6atm1.1Afst/Y
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6NTac
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm9(cre/ESR1)Arte mutation (2 available); any Gt(ROSA)26Sor mutation (993 available)
Kdm6atm1.1Afst mutation (0 available); any Kdm6a mutation (40 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system
N
• tamoxifen-treated mice exhibit normal blood counts





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory